Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

The first major global review of bird flu in cats reveals an emerging threat of a potential human pandemic. Spring is here, ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

During a call with U.S. doctors this month, one CDC official noted that there is a seasonality to bird flu: Cases peak in the ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. | San Diego ...

Our fight against infectious diseases depends on strong intellectual property rights. Bird flu has swept across the United ...

Annual flu shots could become a thing of the past under a new vaccine strategy developed and tested by University of Nebraska ...

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most strains of flu than existing ...